Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
INmune Bio Inc | INMB | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
10.02 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 6.5001 - 14.74 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 10.02 | USD |
INmune Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
180.58M | 18.02M | - | 155k | -30.01M | -1.67 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
INmune Bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INMB Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 11.60 | 11.7584 | 9.90 | 10.64 | 113,494 | -1.58 | -13.62% |
1 Month | 10.39 | 12.72 | 8.30 | 10.71 | 174,962 | -0.37 | -3.56% |
3 Months | 13.90 | 14.41 | 8.30 | 11.09 | 116,932 | -3.88 | -27.91% |
6 Months | 6.82 | 14.74 | 6.63 | 11.18 | 96,215 | 3.20 | 46.92% |
1 Year | 7.83 | 14.74 | 6.5001 | 10.23 | 72,434 | 2.19 | 27.97% |
3 Years | 10.20 | 30.37 | 4.6288 | 14.19 | 142,722 | -0.18 | -1.76% |
5 Years | 10.76 | 30.37 | 2.20 | 14.09 | 174,817 | -0.74 | -6.88% |
INmune Bio Description
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others. |